跳至主要内容
临床试验/NCT00089310
NCT00089310已完成不适用

Intraoperative Sentinel Node Mapping In Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology23 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2004年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
23
主要终点
Sentinel node identification

研究概览

简要总结

RATIONALE: Diagnostic procedures such as sentinel lymph node mapping may improve the ability to detect cancer that has spread to the lymph nodes.

PURPOSE: This clinical trial is studying how well sentinel lymph node mapping works in detecting cancer that has spread to the lymph nodes in patients who are undergoing surgery for stage I non-small cell lung cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the feasibility and accuracy of intraoperative sentinel lymph node mapping using technetium Tc 99 sulfur colloid in patients with stage I non-small cell lung cancer.
  • Determine the percentage of patients in which at least 1 positive sentinel lymph node is identified using this procedure.
  • Determine the percentage of patients undergoing this procedure who are found to have positive sentinel lymph nodes with no metastases in other intrathoracic lymph nodes.

Secondary

  • Determine the percentage of patients undergoing this procedure whose disease stage is upgraded due to detection of micrometastases in sentinel lymph nodes.
  • Correlate the presence of micrometastases in sentinel lymph nodes with survival in patients undergoing this procedure.
  • Determine the percentage of patients undergoing this procedure with "skip metastases" pattern (NZ) sentinel lymph nodes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Sentinel node identification

时间窗: at time of procedure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验